EU → North America Device Access

URSAPHARM Arzneimittel GmbH

DE-MF-000007748 · Germany · Saarbrücken

URSAPHARM Arzneimittel GmbH is registered in the European database on medical devices as a manufacturer, with 44 devices declared. It was not found in the U.S. FDA device establishment register.

What this manufacturer declares

Class IIb30
Class IIa14

Most frequent device types declared: Lubricating eye drops, Lubricating eye ointment, Moistening solution for nasal use, Moistening solution for nasal use (sodium hyaluronate and dexpanthenol, Salt solution for nasal use.

Among these devices, 39 are declared sterile.

Devices declared under this manufacturer

Showing 12 of 44 declared devices.

Catalogue references include 55.0825, 55.1368, 55.1411, 55.1823, 55.2536, 55.2677.

European nomenclature codes declared: Q02030399, Q02030206, Q030103, Q02030301, M9001, Q0299.

United States market access

FDA establishment registerNot found in the FDA register
Devices in EUDAMED44
Country of registrationGermany

⚠️ Not found is not the same as not sold — how this comparison can be wrong.

Device-level evidence

Devices with a numeric GTIN44
Found in the U.S. device database0
Share0.0 %

Canadian market access

Health Canada licence listingLicensed in Canada
Matched entryURSAPHARM ARZNEIMITTEL GMBH

What it holds in Canada

Licences on record6
Currently active0
Class 2 devices6
First licensed2012-07-10

Licence types: Device Family (3), Single Device (3).

Licensed under: HYCOSAN EXTRA, SOLUTION FOR OCULAR USE, HYCOSAN, SOLUTION FOR OCULAR USE, VITA-POS, EYE OINTMENT FOR OCULAR USE, HYLO-PROTECT, SOLUTION FOR OCULAR USE, HYCOSAN LIGHT, SOLUTION FOR OCULAR USE, HYCOSAN PROTECT FORTE.

North American profile: Canada only. URSAPHARM Arzneimittel GmbH holds a Canadian licence but was not found in the U.S. register.

Notified body certificates

CertificateStatusExpiry
HZ 1010771-1supplemented2029-12-12

Other manufacturers in Germany

All Germany manufacturers →